NeuroVision Imaging
Sacramento
About NeuroVision Imaging
NeuroVision is an integrated neuroscience company focused on delivering scientifically validated, diagnostic tests & biomarkers for early detection and monitoring of amyloid pathology related to Alzheimer’s Disease. The company has developed a novel retinal imaging technology, which is currently being utilized in a number of clinical trials globally.With access to unique datasets, we provide data aggregation services, analysis, biostatistics, and applications of machine learning algorithms to large repositories of images and other biomarker data seeking to advance the collective understanding and prediction capabilities for neurodegenerative diseases.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: Less than $1M
- Total funding: $21.2M
- Funding stage: Late Stage Venture
- Last round: Grant (Aug 2021)
- Website: neurovision.com
- Phone: 9167972340
Industries & Categories
Biotechnology, Health Care, Health Diagnostics, Machine Learning, Neuroscience
Canonical: https://fsome.com/organization/neurovision-imaging-51626 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.